PT - JOURNAL ARTICLE AU - Jeroen R Huyghe AU - Tabitha A Harrison AU - Stephanie A Bien AU - Heather Hampel AU - Jane C Figueiredo AU - Stephanie L Schmit AU - David V Conti AU - Sai Chen AU - Conghui Qu AU - Yi Lin AU - Richard Barfield AU - John A Baron AU - Amanda J Cross AU - Brenda Diergaarde AU - David Duggan AU - Sophia Harlid AU - Liher Imaz AU - Hyun Min Kang AU - David M Levine AU - Vittorio Perduca AU - Aurora Perez-Cornago AU - Lori C Sakoda AU - Fredrick R Schumacher AU - Martha L Slattery AU - Amanda E Toland AU - Franzel JB van Duijnhoven AU - Bethany Van Guelpen AU - Volker Arndt AU - Antonio Agudo AU - Demetrius Albanes AU - M Henar Alonso AU - Kristin Anderson AU - Coral Arnau-Collell AU - Barbara Banbury AU - Michael C Bassik AU - Sonja I Berndt AU - Stéphane Bézieau AU - D Timothy Bishop AU - Juergen Boehm AU - Heiner Boeing AU - Marie-Christine Boutron-Ruault AU - Hermann Brenner AU - Stefanie Brezina AU - Stephan Buch AU - Daniel D Buchanan AU - Andrea Burnett-Hartman AU - Bette J Caan AU - Peter T Campbell AU - Prudence Carr AU - Antoni Castells AU - Sergi Castellví-Bel AU - Andrew T Chan AU - Jenny Chang-Claude AU - Stephen J Chanock AU - Keith R Curtis AU - Albert de la Chapelle AU - Douglas F Easton AU - Dallas R English AU - Edith JM Feskens AU - Manish Gala AU - Steven J Gallinger AU - W James Gauderman AU - Graham G Giles AU - Phyllis J Goodman AU - William M Grady AU - John S Grove AU - Andrea Gsur AU - Marc J Gunter AU - Robert W Haile AU - Jochen Hampe AU - Michael Hoffmeister AU - John L Hopper AU - Wan-Ling Hsu AU - Wen-Yi Huang AU - Thomas J Hudson AU - Mazda Jenab AU - Mark A Jenkins AU - Amit D Joshi AU - Temitope O Keku AU - Charles Kooperberg AU - Tilman Kuhn AU - Sébastien Küry AU - Loic Le Marchand AU - Flavio Lejbkowicz AU - Christopher I Li AU - Li Li AU - Wolfgang Lieb AU - Annika Lindblom AU - Noralane M Lindor AU - Satu Männistö AU - Sanford D Markowitz AU - Roger L Milne AU - Lorena Moreno AU - Neil Murphy AU - Rami Nassir AU - Kenneth Offit AU - Shuji Ogino AU - Salvatore Panico AU - Patrick S Parfrey AU - Rachel Pearlman AU - Paul D P Pharoah AU - Amanda I Phipps AU - Elizabeth A Platz AU - John D Potter AU - Ross L Prentice AU - Lihong Qi AU - Leon Raskin AU - Gad Rennert AU - Hedy S Rennert AU - Elio Riboli AU - Clemens Schafmayer AU - Robert E Schoen AU - Daniela Seminara AU - Mingyang Song AU - Yu-Ru Su AU - Catherine M Tangen AU - Stephen N Thibodeau AU - Duncan C Thomas AU - Antonia Trichopoulou AU - Cornelia M Ulrich AU - Kala Visvanathan AU - Pavel Vodicka AU - Ludmila Vodickova AU - Veronika Vymetalkova AU - Korbinian Weigl AU - Stephanie J Weinstein AU - Emily White AU - Alicja Wolk AU - Michael O Woods AU - Anna H Wu AU - Goncalo R Abecasis AU - Deborah A Nickerson AU - Peter C Scacheri AU - Anshul Kundaje AU - Graham Casey AU - Stephen B Gruber AU - Li Hsu AU - Victor Moreno AU - Richard B Hayes AU - Polly A Newcomb AU - Ulrike Peters TI - Genetic architectures of proximal and distal colorectal cancer are partly distinct AID - 10.1101/2020.05.01.20087957 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.01.20087957 4099 - http://medrxiv.org/content/early/2020/05/06/2020.05.01.20087957.short 4100 - http://medrxiv.org/content/early/2020/05/06/2020.05.01.20087957.full AB - Objective An understanding of the etiologic heterogeneity of colorectal cancer (CRC) is critical for improving precision prevention, including individualized screening recommendations and the discovery of novel drug targets and repurposable drug candidates for chemoprevention. Known differences in molecular characteristics and environmental risk factors among tumors arising in different locations of the colorectum suggest partly distinct mechanisms of carcinogenesis. The extent to which the contribution of inherited genetic risk factors for sporadic CRC differs by anatomical subsite of the primary tumor has not been examined.Design To identify new anatomical subsite-specific risk loci, we performed genome-wide association study (GWAS) meta-analyses including data of 48,214 CRC cases and 64,159 controls of European ancestry. We characterized effect heterogeneity at CRC risk loci using multinomial modeling.Results We identified 13 loci that reached genome-wide significance (P<5×10−8) and that were not reported by previous GWAS for overall CRC risk. Multiple lines of evidence support candidate genes at several of these loci. We detected substantial heterogeneity between anatomical subsites. Just over half (61) of 109 known and new risk variants showed no evidence for heterogeneity. In contrast, 22 variants showed association with distal CRC (including rectal cancer), but no evidence for association or an attenuated association with proximal CRC. For two loci, there was strong evidence for effects confined to proximal colon cancer.Conclusion Genetic architectures of proximal and distal CRC are partly distinct. Studies of risk factors and mechanisms of carcinogenesis, and precision prevention strategies should take into consideration the anatomical subsite of the tumor.Significance of this studyWhat is already known about this subject?Heterogeneity among colorectal cancer (CRC) tumors originating at different locations of the colorectum has been revealed in somatic genomes, epigenomes, and transcriptomes, and in some established environmental risk factors for CRC.Genome-wide association studies (GWAS) have identified over 100 genetic variants for overall CRC risk; however, a comprehensive analysis of the extent to which genetic risk factors differ by the anatomical sublocation of the primary tumor is lacking.What are the new findings?In this large consortium-based study, we analyzed clinical and genome-wide genotype data of 112,373 CRC cases and controls of European ancestry to comprehensively examine whether CRC case subgroups defined by anatomical sublocation have distinct germline genetic etiologies.We discovered 13 new loci at genome-wide significance (P<5×10−8) that were specific to certain anatomical sublocations and that were not reported by previous GWAS for overall CRC risk; multiple lines of evidence support strong candidate target genes at several of these loci, including PTGER3, LCT, MLH1, CDX1, KLF14, PYGL, BCL11B, and BMP7.Systematic heterogeneity analysis of genetic risk variants for CRC identified thus far, revealed that the genetic architectures of proximal and distal CRC are partly distinct.Taken together, our results further support the idea that tumors arising in different anatomical sublocations of the colorectum may have distinct etiologies.How might it impact on clinical practice in the foreseeable future?Our results provide an informative resource for understanding the differential role that genes and pathways may play in the mechanisms of proximal and distal CRC carcinogenesis.The new insights into the etiologies of proximal and distal CRC may inform the development of new precision prevention strategies, including individualized screening recommendations and the discovery of novel drug targets and repurposable drug candidates for chemoprevention.Our findings suggest that future studies of etiological risk factors for CRC and molecular mechanisms of carcinogenesis should take into consideration the anatomical sublocation of the colorectal tumor.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding statements and acknowledgements are given in the supplemental text.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll genotype data analyzed in this study have been previously published and have been deposited in the database of Genotypes and Phenotypes (dbGaP), which is hosted by NCBI, under accession numbers phs001415.v1.p1, phs001315.v1.p1, and phs001078.v1.p1. The UK Biobank resource was accessed through application number 8614. CRC-relevant epigenome data were retrieved from the NCBI Gene Expression Omnibus (GEO) database under accession numbers GSE77737 and GSE36401.